Sass, page-71

Been in self imposed exile for a while and just catching up on some HC PAR threads.
I feel the tension.
Looks to me, whether intentional or not, 3rd October (or thereabouts), is a critical point in time for PAR and PR.
If IND gets the tick, all may be forgiven, if it doesn't and PR goes into spin mode, trying to reassure shareholders to remain optimistic, I think even those on the fence will question his ability to manage dual roles at PAR plus his new gig at Neuroscientific BioPharma...
I know I will be making a strategic investment decision based on this announcement.
I will not buy more (irrespective of the news), but I will sell/reduce accordingly, even if it rallies. I will not go to zero shares, as@Mozzarc has mentioned in his posts, this may be a winner eventually and it is worth parking some of these shares away just in case. Which I will do.
I am hopeful of a positive announcement regarding IND, but none of us really know for sure what is going on at the FDA, we can only speculate until we are told something. DYOR & GLTAH